1-3 of 3
Levy D. Pederson
Close
Sort by
Journal Articles

High Efficacy of Lenalidomide Plus R-CHOP (R2CHOP) Combination in First Line Treatment of Activated B-Cell (ABC) DLBCL Defined Using Gene-Expression Prophyling: A Combined Analysis from Two Phase 2 Trials

Alessia Castellino, MD, Annalisa Chiappella, MD, Betsy Laplant, MS, Levy D. Pederson, Giorgio Inghirami, MD, Gianluca Gaidano, MD PhD, William R Macon, MD, Alessandra Tucci, Rebecca L King, MD, Angela Giovanna Congiu, Thomas M. Habermann, MD, Thomas E. Witzig, MD, Umberto Vitolo, Grzegorz S. Nowakowski, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2962.
https://doi.org/10.1182/blood-2018-99-119495
Published: 2018
Journal Articles

Lenalidomide in Combination with Standard R-CHOP Overcomes the Negative Prognostic Value of Peripheral Blood Absolute Lymphocyte/Monocyte Ratio at Diagnosis and during Treatment in Patients with Diffuse Large B-Cell Lymphoma

Alessia Castellino, MD, Levy D. Pederson, Kay M. Ristow, BS, Christina Stenzel, Betsy Laplant, MS, Thomas E. Witzig, MD, Thomas M. Habermann, MD, Grzegorz S. Nowakowski, MD, Luis Porrata, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4139.
https://doi.org/10.1182/blood-2018-99-114010
Published: 2018
Journal Articles

Transcriptome Analysis of Lymphoma Edited Monocyte Phenotype

Yi Lin, MD PhD, Amel Dudakovic, PhD, Roman Thaler, PhD, Ailing Xue, Jennifer Le-Rademacher, PhD, Levy D. Pederson, Dennis A. Gastineau, MD, Allan Dietz, PhD, Andre van Wijnen, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3575.
https://doi.org/10.1182/blood.V130.Suppl_1.3575.3575
Published: 2017